Skip to content

Medtronic plc

NYSE: MDT · USD

Medtronic plc cash flow and EPS83

Operating cash flow, capital investment, free cash flow and earnings per share.

Capital allocation

% of tracked cash uses

$2,853M
Medtronic plc capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2015 Q323.82% · $106M7.42% · $33M0% · $0M67.42% · $300M1.35% · $6M100% · $445M
FY 2015 Q41.54% · $255M86.41% · $14,273M1.82% · $300M2.63% · $435M7.6% · $1,255M100% · $16,518M
FY 2016 Q18.31% · $224M6.64% · $179M27.83% · $750M19.96% · $538M37.25% · $1,004M100% · $2,695M
FY 2016 Q27.68% · $222M28.29% · $818M24.56% · $710M18.57% · $537M20.89% · $604M100% · $2,891M
FY 2016 Q315.16% · $247M8.29% · $135M43.59% · $710M32.72% · $533M0.25% · $4M100% · $1,629M
FY 2016 Q46.86% · $353M1.57% · $81M12.83% · $660M10.32% · $531M68.42% · $3,520M100% · $5,145M
FY 2017 Q112.13% · $330M0.44% · $12M64.79% · $1,763M22.01% · $599M0.62% · $17M100% · $2,721M
FY 2017 Q27.83% · $268M37.83% · $1,294M30.14% · $1,031M17.33% · $593M6.87% · $235M100% · $3,421M
FY 2017 Q319.61% · $326M1.32% · $22M37% · $615M35.5% · $590M6.56% · $109M100% · $1,662M
FY 2017 Q421.14% · $330MUnavailable8.65% · $135M38.05% · $594M32.16% · $502M100% · $1,561M
FY 2018 Q112.97% · $278M0% · $0M57.51% · $1,233M29.15% · $625M0.37% · $8M100% · $2,144M
FY 2018 Q24.28% · $246M1.32% · $76M11.39% · $655M10.81% · $622M72.2% · $4,153M100% · $5,752M
FY 2018 Q325.4% · $252M3.53% · $35M7.66% · $76M62.8% · $623M0.6% · $6M100% · $992M
FY 2018 Q46.71% · $292M0.6% · $26M4.76% · $207M14.34% · $624M73.6% · $3,203M100% · $4,352M
FY 2019 Q115.25% · $291M5.45% · $104M43.19% · $824M35.48% · $677M0.63% · $12M100% · $1,908M
FY 2019 Q29.7% · $206M0.71% · $15M57.61% · $1,223M31.75% · $674M0.24% · $5M100% · $2,123M
FY 2019 Q39.55% · $302M47.31% · $1,496M21.54% · $681M21.22% · $671M0.38% · $12M100% · $3,162M
FY 2019 Q43.61% · $335M2.28% · $212M1.6% · $149M7.23% · $671M85.28% · $7,919M100% · $9,286M
FY 2020 Q14.6% · $301M2.22% · $145M5.09% · $333M11.07% · $724M77.01% · $5,035M100% · $6,538M
FY 2020 Q212.58% · $283M2.49% · $56M27.96% · $629M32.13% · $723M24.84% · $559M100% · $2,250M
FY 2020 Q323% · $293MUnavailable19.31% · $246M56.75% · $723M0.94% · $12M100% · $1,274M
FY 2020 Q417.05% · $336M14.66% · $289M5.99% · $118M36.73% · $724M25.57% · $504M100% · $1,971M
FY 2021 Q129.74% · $334M0% · $0M0% · $0M69.28% · $778M0.98% · $11M100% · $1,123M
FY 2021 Q23.59% · $281M4.73% · $370M0.87% · $68M9.97% · $780M80.84% · $6,325M100% · $7,824M
FY 2021 Q319.37% · $363M32.34% · $606M0.48% · $9M41.68% · $781M6.14% · $115M100% · $1,874M
FY 2021 Q414.14% · $377M0.67% · $18M21.56% · $575M29.28% · $781M34.35% · $916M100% · $2,667M
FY 2022 Q124.55% · $378M0% · $0M20.45% · $315M54.94% · $846M0.06% · $1M100% · $1,540M
FY 2022 Q216.54% · $271M5.56% · $91M26.19% · $429M51.71% · $847M0% · $0M100% · $1,638M
FY 2022 Q321.01% · $330M0% · $0M25.08% · $394M53.91% · $847M0% · $0M100% · $1,571M
FY 2022 Q414.75% · $389M0% · $0M53.3% · $1,406M31.96% · $843M0% · $0M100% · $2,638M
FY 2023 Q18.24% · $426M23.05% · $1,191M6.5% · $336M17.48% · $903M44.73% · $2,311M100% · $5,167M
FY 2023 Q215.8% · $323M33.07% · $676M6.9% · $141M44.23% · $904M0% · $0M100% · $2,044M
FY 2023 Q315.97% · $332M0% · $0M3.42% · $71M43.48% · $904M37.13% · $772M100% · $2,079M
FY 2023 Q48.77% · $378M0% · $0M2.25% · $97M21% · $905M67.97% · $2,929M100% · $4,309M
FY 2024 Q124.86% · $354M0% · $0M10.67% · $152M64.47% · $918M0% · $0M100% · $1,424M
FY 2024 Q228.33% · $461M1.35% · $22M13.89% · $226M56.42% · $918M0% · $0M100% · $1,627M
FY 2024 Q323.91% · $346M3.59% · $52M9.12% · $132M63.37% · $917M0% · $0M100% · $1,447M
FY 2024 Q413.72% · $426M4.41% · $137M52.45% · $1,628M29.41% · $913M0% · $0M100% · $3,104M
FY 2025 Q113.3% · $520MUnavailable63.73% · $2,492M22.97% · $898M0% · $0M100% · $3,910M
FY 2025 Q225.42% · $404MUnavailable18.12% · $288M56.45% · $897M0% · $0M100% · $1,589M
FY 2025 Q328.81% · $476M5.93% · $98M10.96% · $181M54.3% · $897M0% · $0M100% · $1,652M
FY 2025 Q428.16% · $459M0% · $0M16.81% · $274M55.03% · $897M0% · $0M100% · $1,630M
FY 2026 Q118.67% · $504M0% · $0M4.56% · $123M33.72% · $910M43.05% · $1,162M100% · $2,699M
FY 2026 Q213.3% · $468MUnavailable10.57% · $372M25.87% · $910M50.26% · $1,768M100% · $3,518M
FY 2026 Q330.41% · $444MUnavailable7.19% · $105M62.4% · $911M0% · $0M100% · $1,460M
FY 2026 Q421.81% · $488M18.15% · $406M19.45% · $435M40.59% · $908M0% · $0M100% · $2,237M
FY 2027 Q117.63% · $503M40.73% · $1,162M9.36% · $267M32.28% · $921M0% · $0M100% · $2,853M
Jan 23, 2015 through Jul 31, 2026

Operating cash flow

USD millions

$1,793M

Capital expenditures

USD millions

$503M

Free cash flow

USD millions

$1,290M

Stock-based compensation

USD millions

$125M

SBC / free cash flow

% · FCF before SBC deduction

9.69%

SBC / operating cash flow

%

6.97%

Software & intangible investment

USD millions

—

Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.

Diluted EPS

USD per share

$1.14

Quarterly data

Medtronic plc cash-flow history. Each metric has its own unit. A dash means inputs are missing or the calculation is undefined.
Fiscal periodEndedOperating cash flowUSD millionsCapital expendituresUSD millionsFree cash flowUSD millionsStock-based compensationUSD millionsSBC / free cash flow%SBC / operating cash flow%Software & intangible investmentUSD millionsDiluted EPSUSD per share
FY 2027 Q1Jul 31, 20261,7935031,2901259.69%6.97%—$1.14
FY 2026 Q4Apr 24, 20262,5734882,085954.56%3.69%——
FY 2026 Q3Jan 23, 20262,7444442,300944.09%3.43%—$0.89
FY 2026 Q2Oct 24, 202592546845718239.82%19.68%—$1.07
FY 2026 Q1Jul 25, 20251,0885045848614.73%7.9%—$0.81
FY 2025 Q4Apr 25, 20252,5284592,069894.3%3.52%——
FY 2025 Q3Jan 24, 20252,5724762,096984.68%3.81%—$1.01
FY 2025 Q2Oct 25, 202495840455415928.7%16.6%—$0.99
FY 2025 Q1Jul 26, 20249865204668317.81%8.42%—$0.8
FY 2024 Q4Apr 26, 20242,7774262,351903.83%3.24%——
FY 2024 Q3Jan 26, 20242,4743462,128843.95%3.4%—$0.99
FY 2024 Q2Oct 27, 202366146120014673%22.09%—$0.68
FY 2024 Q1Jul 28, 20238753545217314.01%8.34%—$0.59
FY 2023 Q4Apr 28, 20232,4603782,082753.6%3.05%——
FY 2023 Q3Jan 27, 20231,5743321,242816.52%5.15%—$0.92
FY 2023 Q2Oct 28, 202292232359913722.87%14.86%—$0.32
FY 2023 Q1Jul 29, 20221,083426657629.44%5.72%—$0.7
FY 2022 Q4Apr 29, 20222,0573891,668724.32%3.5%——
FY 2022 Q3Jan 28, 20222,2283301,898784.11%3.5%—$1.1
FY 2022 Q2Oct 29, 20211,7692711,4981409.35%7.91%—$0.97
FY 2022 Q1Jul 30, 20211,292378914697.55%5.34%—$0.56
FY 2021 Q4Apr 30, 20211,7453771,368695.04%3.95%——
FY 2021 Q3Jan 29, 20212,3563631,993653.26%2.76%—$0.94
FY 2021 Q2Oct 30, 20201,8612811,5801408.86%7.52%—$0.36
FY 2021 Q1Jul 31, 2020278334-5670—25.18%—$0.36
FY 2020 Q4Apr 24, 20201,4503361,114625.57%4.28%—$0.48
FY 2020 Q3Jan 24, 20202,4072932,114663.12%2.74%—$1.42
FY 2020 Q2Oct 25, 20191,8672831,5841086.82%5.78%—$1.01
FY 2020 Q1Jul 26, 20191,5103011,209615.05%4.04%—$0.64
FY 2019 Q4Apr 26, 20192,0873351,752623.54%2.97%—$0.87
FY 2019 Q3Jan 25, 20192,0553021,753603.42%2.92%—$0.94
FY 2019 Q2Oct 26, 20181,16320695710410.87%8.94%—$0.82
FY 2019 Q1Jul 27, 20181,7022911,411644.54%3.76%—$0.79
FY 2018 Q4Apr 27, 20181,038292746749.92%7.13%—$1.07
FY 2018 Q3Jan 26, 20182,0022521,750724.11%3.6%—$-1.03
FY 2018 Q2Oct 27, 201790724666110616.04%11.69%—$1.48
FY 2018 Q1Jul 28, 20177372784599220.04%12.48%—$0.74
FY 2017 Q4Apr 28, 20171,7733301,443765.27%4.29%—$0.84
FY 2017 Q3Jan 27, 20172,0853261,759824.66%3.93%—$0.59
FY 2017 Q2Oct 28, 20161,4722681,2041119.22%7.54%—$0.8
FY 2017 Q1Jul 29, 20161,5503301,220796.48%5.1%—$0.66
FY 2016 Q4Apr 29, 20161,326353973848.63%6.33%—$0.78
FY 2016 Q3Jan 29, 20161,7972471,550825.29%4.56%—$0.77
FY 2016 Q2Oct 30, 20151,2792221,05711310.69%8.84%—$0.36
FY 2016 Q1Jul 31, 20158162245929616.22%11.76%—$0.57
FY 2015 Q4Apr 24, 20151,9122551,65732419.55%16.95%—$0
FY 2015 Q3Jan 23, 20151,7671061,661331.99%1.87%—$-5,296,000
Sources and calculations

Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.

Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.

FCF subtracts reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Acquisitions and noncash lease additions are excluded. EPS and weighted shares are not summed across quarters. Annual figures use annual reports.

SBC / FCF always uses FCF before SBC deduction; both SBC ratios compare amounts from the same period. A zero or negative cash-flow denominator is undefined, and values above 100% are retained.

Each reported nonnegative cash use / sum of available tracked nonnegative cash uses × 100. Missing categories are omitted, never set to zero. This is the composition of tracked uses, not a complete cash-flow reconciliation or a percentage of OCF. SBC is noncash and excluded. Negative amounts are excluded as reversals or net receipts; they are not converted to spending. Annual bars use reported annual amounts. Turning off a category hides its share without changing the denominator. Debt repayments prefer a reported aggregate, with long-term or convertible-only scope identified in the tooltip. Acquisitions are net of cash acquired. Dividend payments use the aggregate where reported, including dividend equivalents when part of that concept.

The SBC option subtracts reported share-based compensation from FCF as an economic-cost scenario. Missing SBC never becomes zero.

Market prices: Yahoo Finance · MDT, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.

Operating cash flow
Reported net cash provided by or used in operating activities.
Capital expenditures
Reported cash capital investment. Uses purchases of property, plant and equipment where disclosed; otherwise purchases of productive assets, which can also include software and intangibles. Excludes acquisitions and noncash lease additions.
Free cash flow
Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Stock-based compensation
Reported share-based compensation addback in the cash-flow statement. Missing disclosure is not treated as zero.
SBC / free cash flow
Reported share-based compensation / (operating cash flow − cash capital investment) × 100, for the same fiscal period. Always uses FCF before SBC deduction. Zero or negative FCF is undefined; values above 100% are retained.
SBC / operating cash flow
Reported share-based compensation / reported operating cash flow × 100, for the same fiscal period. Zero or negative operating cash flow is undefined. Unaffected by the SBC deduction scenario.
Software & intangible investment
Separately tagged payments for capitalized software under US GAAP, or purchases of intangible assets under IFRS. This optional disclosure is not inferred from total capex or deducted a second time from FCF.
Diluted EPS
Reported diluted earnings per share, normalized for recorded subsequent stock splits. Quarterly EPS is never subtracted from annual or YTD EPS.